APEI American Public Education, Inc.
American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education services in the United States. It operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. The company offers 181 degree programs, 110 certificate programs, and four diploma programs in various fields of study, including public service-focused fields, such as nursing, national security, military studies, intelligence, and homeland security, as well as traditional academic fields comprising business, health science, information technology, justice studies, education, and liberal arts; and career learning and leadership training in-person and online to the federal workforce. It also provides nursing-and health sciences-focused postsecondary education; and pre-licensure nursing education services focusing on a diploma in practical nursing and associate degree in nursing, as well as a bachelor of science in nursing. The company was incorporated in 1991 and is headquartered in Charles Town, West Virginia.…
Industry Peers
Education & Training ServicesKey Statistics
About American Public Education (NASDAQ: APEI)
›
American Public Education (NASDAQ: APEI) is listed on Nasdaq, where its shares trade in USD. It belongs to the Education & Training Services industry, part of the Consumer Defensive sector, and reports about 2,360 employees.
The shares were at 40.84 USD on 19 November 2026, up 33.2% over 52 weeks. Its 52-week range is 30.20 USD to 61.59 USD: the price is 33.7% below the high and 35.2% above the low.
At a market capitalisation of 743.42M USD, it trades at 16.3 times trailing earnings and 11.0 times forward earnings. The median trailing P/E of its 17 largest Education & Training Services peers is 14.6, a premium of 12% for APEI.
American Public Education reports return on equity of 10.7%, an operating margin of 9.4% and revenue up 3.6% year over year.
It holds more cash than debt, a net cash position of 61.37M USD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 6 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 55.83 USD is 36.7% above the current price. The next earnings report is expected on 11 March 2027.